| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;73:1098-1100
© 2002 The Society of Thoracic Surgeons
a Division of General Thoracic Surgery, Keio University Hospital, Tokyo, Japan
Accepted for publication January 4, 2002.
* Address reprint requests to Dr Kawamura, Division of General Thoracic Surgery, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
e-mail: kawamura{at}sc.itc.keio.ac.jp
Background. Fibrin sealant is used in many kinds of surgical procedures. Although pasteurization is insufficient to remove human parvovirus (HPV) B19 from this plasma-derived product, the frequency of HPV B19 infection transmitted by its use has never been known.
Methods. Blood samples of 85 patients more than 20 years of age who had undergone pulmonary resection with fibrin sealant were obtained before and 12, 24, and 48 weeks after surgery. Anti-HPV B19 antibody IgG (HPV B19 IgG) and HPV B19 DNA were detected with these samples.
Results. In 56 (65.9%) of 85 patients, blood samples obtained before operation were positive for HPV B19 IgG. In these 56 patients, blood samples obtained 12 to 48 weeks after surgery were all negative for HPV B19 DNA by polymerase chain reaction (PCR). In 6 (20.7%) of 29 patients whose blood samples were negative for HPV B19 IgG before surgery, blood samples obtained 12 to 48 weeks after surgery were positive for HPV B19 DNA by PCR and also positive for HPV B19 IgG. In 5 of these 6 patients reticulocyte counts decreased to less than 10 x 109/l 12 to 20 days after surgery.
Conclusions. Epidemiologic evidence suggests that more than 20% uninfected persons were subsequently infected with HPV B19 by use of fibrin sealant during surgery.
This article has been cited by other articles:
|
|
 |
|
  M. Takaoka, T. Nakamura, H. Sugai, A. J. Bentley, N. Nakajima, N. Yokoi, N. J. Fullwood, S.-H. Hyon, and S. Kinoshita Novel Sutureless Keratoplasty with a Chemically Defined Bioadhesive Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2679 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Araki, H. Tao, N. Nakajima, H. Sugai, T. Sato, S.-H. Hyon, T. Nagayasu, and T. Nakamura Development of new biodegradable hydrogel glue for preventing alveolar air leakage. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1241 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. R. Schwab, N. T. Johnson, and D. G. Harkin Inherent Risks Associated With Manufacture of Bioengineered Ocular Surface Tissue Arch Ophthalmol, December 1, 2006; 124(12): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Matsumoto, Y. Ohta, M. Oda, Y. Tsunezuka, M. Tamura, K. Kawakami, and G. Watanabe Free Pericardial Fat Pads Can Act as Sealant for Preventing Alveolar Air Leaks Ann. Thorac. Surg., December 1, 2005; 80(6): 2321 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kawamura, M. Gika, Y. Izumi, H. Horinouchi, N. Shinya, M. Mukai, and K. Kobayashi The sealing effect of fibrin glue against alveolar air leakage evaluated up to 48h; comparison between different methods of application Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 39 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L S Alvarenga, G Koranyi, S Seregard, and E D Kopp Comments on using fibrin glue in pterygium surgery Br J Ophthalmol, March 1, 2005; 89(3): 392 - 392. [Full Text] [PDF]
|
|
|
|
|
|
T. Fabian, J. A. Federico, and R. B. Ponn Fibrin glue in pulmonary resection: a prospective, randomized, blinded study Ann. Thorac. Surg., May 1, 2003; 75(5): 1587 - 1592. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
